The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available to you here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by BusinessWire.
Thu, 31.07.2025
Asahi Kasei
JP3111200006
Diversified global manufacturer Asahi Kasei and Toyota Tsusho have established a strategic partnership for the supply of automotive lithium-ion battery (LIB) separator in North America. Their respective subsidiaries in the U.S., Asahi Kasei Battery Separator America, LLC (AKBSA) and Toyota Tsusho America, Inc. (TAI), have finalized a capacity righ...
Diversified global manufacturer Asahi Kasei will supply its Aqualyzer™-C3 containerized 1 MW-class alkaline-water electrolyzer to the Central Finland Mobility Foundation (Cefmof). The system will play an essential role in Central Finland’s hydrogen production and contribute to the region’s decarbonization efforts. Full operation is expected to beg...
Asahi Kasei Life Science, a division of diversified global manufacturer Asahi Kasei, announced plans to construct a new spinning plant for its Planova™ virus removal filters in Nobeoka City, Miyazaki, Japan. The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters. Construction is scheduled to begin ...
Japanese technology company Asahi Kasei has announced that its Microza & Water Processing Division, which provides Microza® hollow-fiber membranes for filtration and separation, received a Gold rating in the EcoVadis sustainability assessment conducted in June 2025. EcoVadis is a sustainability assessment company based in France that performs ...
Asahi Kasei Pharma has started trial drug administration in a Phase III study of ART-123 in Japan (generic name: thrombomodulin alfa; marketed as Recomodulin™ Injection in Japan) for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) related symptoms. This announcement follows encouraging data from earlier Phase I and II studies p...
Asahi Kasei has received the 2025 Imperial Invention Prize from the Japan Institute of Invention and Innovation, the highest award presented at the 2025 National Commendation for Invention. The formal award ceremony is scheduled to be held on July 1, 2025. The company was honored for its invention of a nickel-coated absorption layer, which extends...
Asahi Kasei has developed the TA Series of Sunfort™ dry film photoresist as a new product designed to meet growing demand in the field of advanced semiconductor packages used in applications such as artificial intelligence (AI) servers. This product is positioned as a strategic offering within Asahi Kasei's Material sector, aiming to strengthen it...
Leading semiconductor manufacturer Asahi Kasei Microdevices (AKM) and Swedish digital audio pioneer Dirac have announced a partnership to integrate Dirac’s suite of software-defined smart acoustics solutions, AudioIQ, into AKM’s line of automotive audio digital signal processors (DSPs), including its flagship AK7709, to significantly reduce tuning...
Asahi Kasei Bioprocess America (AKBA) and PeptiSystems have announced a strategic, exclusive partnership aimed at delivering a streamlined process to the peptide manufacturing industry. This collaboration establishes AKBA as the exclusive OEM for peptide synthesis columns to PeptiSystems, which carries out R&D, manufacturing, and supply of ins...
On March 25, Japanese technology company Asahi Kasei was awarded the prestigious Okochi Memorial Prize, which acknowledges significant contributions to the areas of production engineering, production technology R&D, and the implementation of high-level production methods in Japan. The Okochi Memorial Foundation recognized the contribution of A...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .